These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. A 5' dystrophin duplication mutation causes membrane deficiency of alpha-dystroglycan in a family with X-linked cardiomyopathy. Bies RD; Maeda M; Roberds SL; Holder E; Bohlmeyer T; Young JB; Campbell KP J Mol Cell Cardiol; 1997 Dec; 29(12):3175-88. PubMed ID: 9441825 [TBL] [Abstract][Full Text] [Related]
3. Association of nonsense mutation of dystrophin gene with disruption of sarcoglycan complex in X-linked dilated cardiomyopathy. Franz WM; Müller M; Müller OJ; Herrmann R; Rothmann T; Cremer M; Cohn RD; Voit T; Katus HA Lancet; 2000 May; 355(9217):1781-5. PubMed ID: 10832829 [TBL] [Abstract][Full Text] [Related]
4. Novel mutation in splicing donor of dystrophin gene first exon in a patient with dilated cardiomyopathy but no clinical signs of skeletal myopathy. Kimura S; Ikezawa M; Ozasa S; Ito K; Ueno H; Yoshioka K; Ijiri S; Nomura K; Nakamura K; Matuskura M; Miike T J Child Neurol; 2007 Jul; 22(7):901-6. PubMed ID: 17715288 [TBL] [Abstract][Full Text] [Related]
5. Dilated cardiomyopathy mutations in δ-sarcoglycan exert a dominant-negative effect on cardiac myocyte mechanical stability. Campbell MD; Witcher M; Gopal A; Michele DE Am J Physiol Heart Circ Physiol; 2016 May; 310(9):H1140-50. PubMed ID: 26968544 [TBL] [Abstract][Full Text] [Related]
6. Sarcoglycans in muscular dystrophy. Hack AA; Groh ME; McNally EM Microsc Res Tech; 2000 Feb 1-15; 48(3-4):167-80. PubMed ID: 10679964 [TBL] [Abstract][Full Text] [Related]
7. [Mutations of the dystrophin gene in dilated cardiomyopathy]. Shiga N; Akita H; Yokoyama M Nihon Rinsho; 2000 Jan; 58(1):123-7. PubMed ID: 10885299 [TBL] [Abstract][Full Text] [Related]
8. Consequences of disrupting the dystrophin-sarcoglycan complex in cardiac and skeletal myopathy. Heydemann A; McNally EM Trends Cardiovasc Med; 2007 Feb; 17(2):55-9. PubMed ID: 17292047 [TBL] [Abstract][Full Text] [Related]
9. Identification of functional domains in sarcoglycans essential for their interaction and plasma membrane targeting. Chen J; Shi W; Zhang Y; Sokol R; Cai H; Lun M; Moore BF; Farber MJ; Stepanchick JS; Bönnemann CG; Chan YM Exp Cell Res; 2006 May; 312(9):1610-25. PubMed ID: 16524571 [TBL] [Abstract][Full Text] [Related]
10. Multiple pathogenetic mechanisms in X linked dilated cardiomyopathy. Cohen N; Muntoni F Heart; 2004 Aug; 90(8):835-41. PubMed ID: 15253946 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of sarcoglycans, vinculin-talin-integrin system and filamin2 in alpha- and gamma-sarcoglycanopathy: an immunohistochemical study. Anastasi G; Cutroneo G; Trimarchi F; Santoro G; Bruschetta D; Bramanti P; Pisani A; Favaloro A Int J Mol Med; 2004 Dec; 14(6):989-99. PubMed ID: 15547664 [TBL] [Abstract][Full Text] [Related]
13. [Gene errors of dilated cardiomyopathy]. Heliö T; Kaartinen M; Kärkkäinen S; Peuhkurinen K Duodecim; 2001; 117(18):1797-800. PubMed ID: 12181975 [No Abstract] [Full Text] [Related]
14. Follow-up of three patients with a large in-frame deletion of exons 45-55 in the Duchenne muscular dystrophy (DMD) gene. Nakamura A; Yoshida K; Fukushima K; Ueda H; Urasawa N; Koyama J; Yazaki Y; Yazaki M; Sakai T; Haruta S; Takeda S; Ikeda S J Clin Neurosci; 2008 Jul; 15(7):757-63. PubMed ID: 18261911 [TBL] [Abstract][Full Text] [Related]
15. Cardiomyopathy is independent of skeletal muscle disease in muscular dystrophy. Zhu X; Wheeler MT; Hadhazy M; Lam MY; McNally EM FASEB J; 2002 Jul; 16(9):1096-8. PubMed ID: 12039854 [TBL] [Abstract][Full Text] [Related]
16. The mouse dystrophin muscle enhancer-1 imparts skeletal muscle, but not cardiac muscle, expression onto the dystrophin Purkinje promoter in transgenic mice. De Repentigny Y; Marshall P; Worton RG; Kothary R Hum Mol Genet; 2004 Nov; 13(22):2853-62. PubMed ID: 15385445 [TBL] [Abstract][Full Text] [Related]
17. Mutations in the human delta-sarcoglycan gene in familial and sporadic dilated cardiomyopathy. Tsubata S; Bowles KR; Vatta M; Zintz C; Titus J; Muhonen L; Bowles NE; Towbin JA J Clin Invest; 2000 Sep; 106(5):655-62. PubMed ID: 10974018 [TBL] [Abstract][Full Text] [Related]
18. Epsilon-sarcoglycan compensates for lack of alpha-sarcoglycan in a mouse model of limb-girdle muscular dystrophy. Imamura M; Mochizuki Y; Engvall E; Takeda S Hum Mol Genet; 2005 Mar; 14(6):775-83. PubMed ID: 15689353 [TBL] [Abstract][Full Text] [Related]
19. [Gamma-sarcoglycanopathy: clinico-pathological and genetic study of 11 cases]. García-García D; Teijeira-Bautista S; Fernández-Rodríguez JM; Flores-Calvete J; Sánchez-Espíldora P; Fernández-Couto D; Cimas-Hernando I; Teijeiro-Ferreira A; Fernández-Hojas R; Brasa-Fernández Fierros J; Martínez de Alegría A; Escribano-Arias JL; Núñez-Delgado M; Navarro-Fernández Balbuena C Rev Neurol; 1998 Jun; 26(154):905-11. PubMed ID: 9658457 [TBL] [Abstract][Full Text] [Related]
20. A novel Alu-like element rearranged in the dystrophin gene causes a splicing mutation in a family with X-linked dilated cardiomyopathy. Ferlini A; Galié N; Merlini L; Sewry C; Branzi A; Muntoni F Am J Hum Genet; 1998 Aug; 63(2):436-46. PubMed ID: 9683584 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]